Literature DB >> 33592878

Clinical features and risk factors for severe-critically ill COVID-19 adult patients in Jiangsu, China: A multiple-centered, retrospective study.

Jiangnan Zhao1,2, Meiying Zhu1, Xin Su1, Mao Huang3, Yi Yang4, Jianan Huang5, Ni Songshi6, Quan Cao7, Qin Gu8, Jun Li9, Jiashu Li10, Wenjing Zhao11, Bin Shi12, Yi Shi1.   

Abstract

ABSTRACT: Coronavirus disease 2019 (COVID-19) becomes a global pandemic in 2020. Early identification of severe ill patients is a top priority for clinicians. We aimed to describe clinical features and risk factors of severe-critically ill patients with COVID-19 in Jiangsu Province.This multi-centered retrospective study collected the information of 631 laboratory-confirmed COVID-19 patients hospitalized at 28 authorized hospitals in Jiangsu province from January 23, 2019 to March 13, 2020.A total of 583 adult patients with laboratory-confirmed COVID-19 were enrolled for final analysis, including 84 severe-critically ill patients and 499 mild-moderate patients. Median age of the severe-critically ill patients was 57.0 years old (interquartile range, 49.0-65.8), and 50 (59.5%) were males. Multisystemic laboratory abnormalities were observed on admission for severe-critically ill patients. These patients showed more noticeable radiologic abnormalities and more coexisting health issues as compared to the mild-moderate patients. Most of the severe-critically ill COVID-19 patients became deteriorated in 2 weeks after diagnosis. Age, D-dimer, and lymphocytes were independently associated with the progression of severe-critically illness.Older age, higher D-dimer levels and less lymphocyte counts on admission are potential risk factors for COVID-19 patients to develop into severe and critically illness.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Year:  2021        PMID: 33592878     DOI: 10.1097/MD.0000000000024332

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  4 in total

Review 1.  Heterogeneity and Risk of Bias in Studies Examining Risk Factors for Severe Illness and Death in COVID-19: A Systematic Review and Meta-Analysis.

Authors:  Abraham Degarege; Zaeema Naveed; Josiane Kabayundo; David Brett-Major
Journal:  Pathogens       Date:  2022-05-10

Review 2.  Association between viral hepatitis and increased risk of severe coronavirus disease 2019 (COVID-19) outcome: a systematic review and meta-analysis.

Authors:  Timotius Ivan Hariyanto; Claudia Jodhinata; Devina Adella Halim; Andree Kurniawan
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2022

3.  Meta-Analysis and Systematic Review of Coagulation Disbalances in COVID-19: 41 Studies and 17,601 Patients.

Authors:  Polina Len; Gaukhar Iskakova; Zarina Sautbayeva; Aigul Kussanova; Ainur T Tauekelova; Madina M Sugralimova; Anar S Dautbaeva; Meruert M Abdieva; Eugene D Ponomarev; Alexander Tikhonov; Makhabbat S Bekbossynova; Natasha S Barteneva
Journal:  Front Cardiovasc Med       Date:  2022-03-11

4.  COVID-19 susceptibility variants associate with blood clots, thrombophlebitis and circulatory diseases.

Authors:  Areti Papadopoulou; Hanan Musa; Mathura Sivaganesan; David McCoy; Panos Deloukas; Eirini Marouli
Journal:  PLoS One       Date:  2021-09-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.